Current Projects
Basic Science
Our basic science research focuses on understanding the genetic and cell biology mechanisms of disease. This broad focus includes studies aimed at understanding the mechanism of mutation and its subsequent biology; we seek to reveal these mechanisms all the way down to the subcellular level.
We use the results from our basic science experiments to develop therapeutic approaches, which we then test in cell- and animal-based models. When these approaches show promise, we develop them into clinical trials.
Clinical Research
John Bissler attends the Tuberous Sclerosis Clinic in Cincinnati, one of the largest TS clinics in the world, where he cares for the renal component of this disease process. His current clinical research investigates the use of mTORC1 inhibitors to reduce the tumor and cystic burden in tuberous sclerosis complex. Understanding the dosing, frequency and duration of mTORC1 inhibition may reveal ways to optimize therapy while reducing side effects.
His second clinical research project revolves around the computerization of hemodialysis and hemofiltration. This research has led to several patents, which create a revenue stream that funds further research in our lab.
